Related Experiment Videos
Genetic variation and psoriasis
1Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA. johanng@med.umich.edu
Summary
Psoriasis genetics reveal autoimmune links, involving HLA-C, IL-23, and beta-defensins. Understanding these genetic variants offers potential pathways toward curing this chronic inflammatory skin disease.
Area of Science:
- Immunology
- Genetics
- Dermatology
Background:
- Psoriasis is a prevalent chronic inflammatory skin condition with a significant genetic component.
- It involves complex changes in epidermal growth and differentiation.
- The genetic underpinnings of psoriasis have been recognized for decades, with recent identification of key variants.
Purpose of the Study:
- To identify and elucidate the genetic variants contributing to psoriasis pathogenesis.
- To understand the autoimmune basis and T-cell mediated mechanisms in psoriasis.
- To explore the role of cytokines, antimicrobial peptides, and signaling pathways in disease development.
Main Methods:
- Genetic association studies to identify specific gene variants (e.g., HLA-C, IL12B, IL-23 receptor, SNF313).
- Analysis of gene copy number variations (e.g., beta-defensin gene cluster).
- Investigation of protein expression (e.g., beta-defensin 2) in lesional skin.
Main Results:
- Identified key genetic variants including HLA-Cw*0602, IL-12/IL-23 (IL12B), IL-23 receptor, and SNF313.
- Observed increased copy numbers of the beta-defensin gene cluster on chromosome 8 in psoriasis patients.
- Found elevated levels of beta-defensin 2 in lesional skin, possessing cytokine-like and antimicrobial properties.
Conclusions:
- Identified genetic variants support an autoimmune etiology for psoriasis, likely involving T-cells and the IL-23 cytokine axis.
- An exaggerated antimicrobial response (beta-defensins) and signaling pathway dysregulation (ubiquitination) contribute to the pro-inflammatory environment.
- Further elucidation of psoriasis genetics and pathogenic mechanisms holds promise for developing curative therapies.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:25Genetic Variation
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...
Genes exist in different versions called alleles, which...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:09Mutation, Gene Flow, and Genetic Drift
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).Mechanisms of Genetic VariationThe original sources of genetic variation are mutations,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...